Результаты поиска

Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation.

BACKGROUND: CAR T-cell therapy has become a highly effective treatment for hematological malignancies, and emerging evidence indicates promising benefits for non-oncohematological conditions. As its clinical use broadens, understanding long-term outcomes and late complications is crucial. One critical yet understudied area is fertility, for which current evidence remains limited and no formal guidelines provide direction for patients undergoing CAR T-cell therapy. METHODS: To address this gap, we conducted a cross-sectional survey on behalf of the Cellular Therapy and Immunobiology Working Pa

Совпадение в полном тексте источника
… Access to specialized consultations was widely available, with 65% of centers (33/51) reporting the availability of a dedicated multidisciplinary team including gynaecologists, endocrinologists, or fertility specialists. …

Изучение протеомных иммунопрофилей: общие неврологические и иммунологические пути в множестве склерозов и типов 1 Болит диабет.

СПРАВОЧНАЯ ИНФОРМАЦИЯ: Интерес к изучению типа 1 Уровень сахарного диабета (T1DM) и множественного склероза (MS) возрос в связи с их значительным негативным воздействием на качество жизни пациентов и серьезными последствиями для системы здравоохранения. Хотя клинические симптомы T1DM отличаются от таких симптомов MS, как поджелудочная неисправность β-клеток в T1DM и демиелинация в центральной нервной системе (CNS) в MS, обе патологии рассматриваются в качестве аутоиммунных заболеваний с общими патогенными путями, которые включают, в частности, автофагию, воспаление и дегенерацию. Учитывая труд

Совпадение в полном тексте источника
… The patient recruitment process was carried out by qualified neurologists and endocrinologists from the same hospital, following the most widely used diagnostic criteria at the time of diagnosis: the ADA criteria (Care and Suppl 2021 ) for T1DM and the McDonald criteria (Polman et al. 2011 ) for MS …

The Interplay between Immune System and Microbiota in Osteoporosis.

Osteoporosis is a disease characterized by low bone mass and alterations of bone microarchitecture, with an increased risk of fractures. It is a multifactorial disorder that is more frequent in postmenopausal women but can be associated to other diseases (inflammatory and metabolic diseases). At present, several options are available to treat osteoporosis trying to block bone reabsorption and reduce the risk of fracture. Anyway, these drugs have safety and tolerance problems in long-term treatment. Recently, gut microbiota has been highlighted to have strong influence on bone metabolism, becom

Integration of Chronic Oncology Services in Noncommunicable Disease Clinic in Rural Rwanda.

BackgroundIn rural sub-Saharan Africa, access to care for severe non-communicable diseases (NCDs) is limited due to myriad delivery challenges. We describe the implementation, patient characteristics, and retention rate of an integrated NCD clinic inclusive of cancer services at a district hospital in rural Rwanda.MethodsIn 2006, the Rwandan Ministry of Health at Rwinkwavu District Hospital (RDH) and Partners In Health established an integrated NCD clinic focused on nurse-led care of severe NCDs, within a single delivery platform. Implementation modifications were made in 2011 to include cance

Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk.

The study aimed to perform a systematic review and meta-analysis of the evidence for the prevention of future cancers following bariatric surgery. A systematic literature search of the Cochrane Library, Embase, Scopus, Web of Science and PubMed databases (2007-2023), Google Scholar and grey literature was conducted. A meta-analysis was performed using the inverse variance method and random effects model. Thirty-two studies involving patients with obesity who received bariatric surgery and control patients who were managed with conventional treatment were included. The meta-analysis suggested b

Совпадение в полном тексте источника
… This is according to the updated 2019 clinical guidelines by the American Association of Clinical Endocrinologists and the American Society for Metabolic and Bariatric Surgery. … Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures—2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic …

Снижение уровня эстрогена лимфатического узла вызывает неиспускающее заболевание аутоиммунной энцефаломиелита.

Эстроген, стероидный гормон, синтезированный как гонадальными, так и негональными тканями, играет ключевую роль в модуляции иммунной реакции, включая снижение частоты рецидивов при повторном излучающем многократном склерозе (МС). В этом исследовании изучалось выражение ароматазы, фермента, ответственного за синтез эстрогенов, в лимфатических узлах (ЛН) и его потенциальная роль в патогенезе MS с использованием модели мыши. Мы использовали мыши Cyp19-RFP, где клетки, которые выражают или ранее выражали ген Cyp19 (кодирование ароматазы), обозначаются красным флуоресцентным белком (RFP). RPF был о

Совпадение в полном тексте источника
… However, while estrogen treatment produced promising outcomes, clinicians and endocrinologists have significant concerns regarding the negative impact of prolonged systemic estrogen treatment on cancer risk, fertility, and mood ( 62 , 63 ). …

Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study.

Background and objective: There is limited information as to the association of several key bone markers with bone mineral density (BMD) in understudied ethnic groups. This study investigated the relationship between circulating levels of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-Β ligand (RANKL) with BMD in Arab postmenopausal women. Materials and methods: In this cross-sectional study, a total of 617 Saudi postmenopausal women from the Osteoporosis Registry of the Chair for Biomarkers of Chronic Diseases were included. Anthropometric data, BMD, and biochemical data

Совпадение в полном тексте источника
… American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis Endocr. Pract. 2010 16 1016 10.4158/EP.16.6.1016 21216723 PMC4890158 2. Baron R. Kneissel M. …

Preoperative treatment and postoperative outcomes in osteoporotic patients with vertebral fractures: a longitudinal database study.

INTRODUCTION: This study aimed to investigate perioperative treatment and postoperative outcomes in osteoporotic patients with vertebral fractures (VFs), categorized by the type of spine surgery. MATERIALS AND METHODS: Patients aged ≥ 40, diagnosed with VFs and osteoporosis, with initial spine surgery between April 2015 and February 2021, were analyzed using a Japanese claims database. Time-to-event analysis was conducted for postoperative outcome. Outcome-related factors were explored with a multivariable Cox proportional hazards model. RESULTS: The study population (n = 4870) consisted of

Совпадение в полном тексте источника
… Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis …

Effect of pilose antler polypeptide on the mechanism of bone homeostasis in osteoporosis.

Osteoporosis stands out as a prevalent metabolic disorder, bearing significant repercussions on human well-being and overall quality of life. It remains an urgent concern within the global public health framework due to its widespread occurrence. Osteoporosis arises from an abnormal metabolism in osteoblasts and osteoclasts, resulting in a disruption of the delicate equilibrium between bone formation and bone resorption. Within this context, deer antler peptides emerge as natural active compounds, wielding a pivotal role in governing the differentiation, proliferation, and mineralization of os

Совпадение в полном тексте источника
… American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal Osteoporosis-2020 update. Endocr Pract. (2021) 27:379–80. doi: 10.1016/j.eprac.2021.02.001, PMID: 86. Huo YS, Huo H, Zhang J. …

The Treatment Gap in Osteoporosis.

Worldwide, there are millions of people who have been diagnosed with osteoporosis, a bone disease that increases the risk of fracture due to low bone mineral density and deterioration of bone architecture. In the US alone, there are approximately ten million men and women diagnosed with osteoporosis and this number is still growing. Diagnosis is made by measuring bone mineral density. Medications used for the treatment of osteoporosis are bisphosphonates, denosumab, raloxifene, and teriparatide. Recently, romosozumab has been added as well. In recent years, a number of advances have been made

Совпадение в полном тексте источника
… American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis. Endocr. Pract. 2016;22:1–42. doi: 10.4158/EP161435.GL. 30. Shakeri A., Adanty C. …

Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.

IntroductionSomapacitan is a long-acting growth hormone (GH) derivative approved for once-weekly treatment of adult GH deficiency (AGHD). This study aimed to evaluate the efficacy and safety of somapacitan and daily GH in Japanese individuals with AGHD.MethodsThis subgroup study included the 34-week main period of the multinational, randomized, parallel-group, phase 3 trial, REAL 1 (NCT02229851). Participants received once-weekly somapacitan or daily GH (Norditropin®), both administered subcutaneously. Investigators and trial sites were blinded. A total of 36 Japanese GH-naïve individuals with

Совпадение в полном тексте источника
… American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract. (2019) 25:1191–232. doi: 10.4158/GL-2019-0405 19. …

Drug Repurposing of New Treatments for Neuroendocrine Tumors.

Drug repurposing or drug repositioning is the process of identifying new therapeutic uses for approved or investigational drugs beyond the original treatment indication. The discovery of new drugs for cancer therapy needs this cost-effective and time-saving alternative strategy to traditional drug development for a rapid clinical translation in Phase II/III studies, especially for unmet medical needs and rare diseases. Neuroendocrine tumors (NETs) are a heterogeneous group of rare neoplasms arising from cells of the neuroendocrine system that, though often indolent, can be aggressive and metas

Совпадение в полном тексте источника
… In clinical practice, the therapeutic strategy is generally performed by a multidisciplinary team of NET specialists, including oncologists, endocrinologists, nuclear medicine physicians, radiologists, pathologists, radiotherapists, and surgeons. …

Intranasal insulin for improving cognitive function in multiple sclerosis.

Cognitive impairment is common in people with multiple sclerosis (PwMS). There is an urgent need to identify/develop novel therapies that can help cognitive function in MS. Insulin is critical for helping with regulation of multiple CNS functions, including learning and memory. Insulin administrated intranasally has shown to improve memory and learning in healthy people and in those with some neurodegenerative disorders. Hence, there was rationale for investigating intranasal insulin in PwMS who experience cognitive impairment. We completed a phase Ib/II, randomized, double-blind, placebo-cont

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases.

Bone metastases frequently occur in patients with advanced solid tumors, particularly breast and prostate cancers, and nearly all patients with multiple myeloma have some degree of skeletal involvement. The strides made in treating these primary tumors have extended median survival times and thereby increased patient risk for skeletal-related events (SREs), including pathologic fractures, spinal cord compression, need for palliative radiation therapy or surgery to bone, and hypercalcemia. Bisphosphonates, inhibitors of osteoclastic bone resorption that were first established as treatment of os

Совпадение в полном тексте источника
… References 1 Sambrook P Cooper C Osteoporosis Lancet 2006 367 9527 2010 2018 16782492 10.1016/S0140-6736(06)68891-0 2 Hodgson SF Watts NB for AACE Osteoporosis Task Force American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal …

Impacts of Prior Anti-Osteoporosis Treatments on Sequential Denosumab Responses in BMD Changes Among Postmenopausal Osteoporosis Women in East China: Real-World Data Analysis.

PURPOSE: This study aimed to investigate the impacts of prior anti-osteoporosis treatments on bone mineral density (BMD) changes in Chinese postmenopausal women with osteoporosis following 1-year Denosumab (Dmab) therapy. PATIENTS AND METHODS: This retrospective cohort study enrolled 381 postmenopausal women, all receiving a 1-year Dmab treatment. Participants were stratified into five groups based on prior anti-osteoporosis treatments: no treatment (NT), alendronate (ALN), zoledronic acid (ZOL), teriparatide (TPT), and raloxifene (RAL). Potential factors influencing BMD changes were screened

Совпадение в полном тексте источника
… American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract . 2020;26(Suppl 1):1–46. doi: 10.4158/GL-2020-0524SUPPL 16. …

A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer.

PURPOSE: This observational case registry study was designed to describe the natural history of cancer patients with medication-related osteonecrosis of the jaw (ONJ) and evaluate the ONJ resolution rate. METHODS: Adults with a diagnosis of cancer and with a new diagnosis of ONJ were enrolled and evaluated by a dental specialist at baseline and every 3 months for 2 years and then every 6 months for 3 years until death, consent withdrawal, or loss to follow-up. The primary endpoint was the rate and time course of ONJ resolution. Secondary endpoints included frequency of incident ONJ risk facto

Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.

Recent trials underscore the cardiovascular (CV), renal, and metabolic benefits of semaglutide in individuals with and without type 2 diabetes (T2D). In T2D, semaglutide enhances glycemic control, reduces major adverse CV events (MACE), and slows chronic kidney disease (CKD) progression. The SUSTAIN-6 trial demonstrated a 26% MACE reduction (HR 0.74; 95% CI: 0.58-0.95; p = 0.02) in high CV-risk patients with T2D using semaglutide (0.5 or 1.0 mg weekly). Similarly, the FLOW trial showed a 24% reduction in major kidney disease events (HR 0.76; 95% CI: 0.66-0.88; p = 0.002) with weekly 1.0 mg sem

Совпадение в полном тексте источника
… Not only are patients with T2D more likely to see a cardiologist than an endocrinologist – especially those with ASCVD – but cardiologists are also trusted advisors in reducing CV risks [ 189 ]. … Cardiologists, endocrinologists, and primary care providers should consider advocating for the use of semaglutide in high-risk CKM patients, given its potential to address interconnected metabolic, CV, and kidney disorders. …

Распространение остеопороза в хронических заболеваниях: зонтичный обзор 283 наблюдения, полученные в ходе 13 систематического обзора.

ВВЕДЕНИЕ: Остеопороз - это болезнь, характеризующаяся снижением плотности минералов кости и ухудшением микроархитектуры кости, что повышает риск разрушения. В контексте различных хронических патологий это состояние может привести к еще более высокому уровню заболеваемости, смертности и бремени здравоохранения. ЦЕЛЬ: Обобщать и сопоставлять имеющиеся данные, полученные в ходе систематических обзоров распространения остеопороза среди различных хронических заболеваний. МЕТОДОЛОГИЯ: В соответствии с руководящими принципами ПРИСМА был проведен зонтичный обзор с уделением особого внимания систематич

Совпадение в полном тексте источника
… Such initiatives require the coordination of pulmonologists, endocrinologists, rheumatologists, physiotherapists, and nutritionists, who must work in an integrated manner to address the underlying disease and bone health simultaneously. …

Bone Metastases: An Overview.

Bone is a frequent site of metastases and typically indicates a short-term prognosis in cancer patients. Once cancer has spread to the bones it can rarely be cured, but often it can still be treated to slow its growth. The majority of skeletal metastases are due to breast and prostate cancer. Bone metastasis is actually much more common than primary bone cancers, especially in adults. The diagnosis is based on signs, symptoms and imaging. New classes of drugs and new interventions are given a better quality of life to these patients and improved the expectancy of life. It is necessary a multid

Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity.

The goal of the 8th edition of the Clinical Practice Guidelines for Obesity is to help primary care physician provide safe, effective care to patients with obesity by offering evidence-based recommendations to improve the quality of treatment. The Committee for Clinical Practice Guidelines comprised individuals with multidisciplinary expertise in obesity management. A steering board of seven experts oversaw the entire project. Recommendations were developed as the answers to key questions formulated in patient/problem, intervention, comparison, outcomes (PICO) format. Guidelines underwent mult

Совпадение в полном тексте источника
… Personnel involved in the development of the guidelines The Committee of Clinical Practice Guidelines comprised multidisciplinary experts in obesity management including family physicians, endocrinologists, clinical nutritionists, exercise specialists, pediatricians, surgeons, and psychiatrists. … American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22 Suppl 3:1–203. doi: 10.4158/EP161365.GL. 22. …